Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
10.24
+0.07 (0.69%)
At close: Feb 27, 2026
SHE:300534 Revenue
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had revenue of 151.06M CNY in the quarter ending September 30, 2025, a decrease of -34.63%. This brings the company's revenue in the last twelve months to 914.65M, down -12.01% year-over-year. In the year 2024, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had annual revenue of 1.04B, down -3.79%.
Revenue (ttm)
914.65M
Revenue Growth
-12.01%
P/S Ratio
3.40
Revenue / Employee
1.44M
Employees
634
Market Cap
3.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.04B | -40.98M | -3.79% |
| Dec 31, 2023 | 1.08B | 280.37M | 35.06% |
| Jan 1, 2023 | 799.68M | 511.87M | 177.85% |
| Jan 1, 2022 | 287.81M | 32.91M | 12.91% |
| Dec 31, 2020 | 254.90M | 15.90M | 6.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Guizhou Yibai Pharmaceutical | 1.91B |
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Jiangxi Synergy Pharmaceutical | 825.20M |
| Ginwa Enterprise (Group) | 550.44M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |